There were no significant between-group differences in pregnancy loss ( 49 of 154 pregnancies in the letrozole group [ 31.8 % ] and 30 of 103 pregnancies in the clomiphene group [ 29.1 % ] ) or twin pregnancy ( 3.4 % and 7.4 % , respectively ) .